Thursday Aug 28
San Jose Mercury News investigates the drugging of California foster children
With alarming frequency, foster and health care providers are turning to a risky but convenient remedy to control the behavior of thousands of troubled kids: numbing them with psychiatric drugs that are untested on and often not approved for children.
Thursday Aug 28
Schizophrenia treatment improved with ACCESS
Patients treated for schizophrenia or bipolar I disorder under the ACCESS model have low levels of service disengagement, high levels of medication adherence and improvements in clinical outcomes, researchers report.
Tue Aug 26, 2014
Alkermes submits new schizophrenia drug for U.S. approval
Alkermes' drug aimed at schizophrenia is a reformulation of the well-known anti-psychotic Abilify.
Mon Aug 25, 2014
Regulatory Approval Sought for Long-Acting Schizophrenia Treatment Aripiprazole Lauroxil
A new drug application has been submitted to the FDA for approval of aripiprazole lauroxil , an investigational, once-monthly, long-acting injectable atypical antipsychotic for the treatment of schizophrenia.
Alkermes Submits New Drug Application to FDA for Aripiprazole...
Alkermes today announced that it has submitted a New Drug Application to the U.S. Food and Drug Administration for approval of aripiprazole lauroxil, the company's investigational, novel, once-monthly, long-acting injectable atypical antipsychotic for the treatment of schizophrenia.
Sat Aug 23, 2014
Low Motivation Is A Symptom Of Schizophrenia, But Scientists May Have Found A Way To Treat It
Schizophrenics have trouble accomplishing goals because they perceive the work as being more difficult than it actually is.
Sun Aug 17, 2014
Omeros Corporation Estimates May Vary
Though virtually everything has gone well at Omeros Corporation since February 2013, the biopharmaceutical firm's stock remains speculative.
Sat Aug 16, 2014
Comparative efficacy and tolerability of 15 antipsychotic drugs in...
The question of which antipsychotic drug should be preferred for the treatment of schizophrenia is controversial, and conventional pairwise meta-analyses cannot provide a hierarchy based on the randomised evidence.
Neurocognition and its influencing factors in the treatment of...
To examine influencing variables of neurocognition in patients with schizophrenia and to predict cognition during antipsychotic treatment.
Quetiapine versus other atypical antipsychotics for schizophrenia.
In many countries, second-generation antipsychotic drugs have become the first-line drug treatment for people with schizophrenia.
The management of schizophrenia: focus on extended-release quetiapine fumarate.
Effective management of schizophrenia remains a significant clinical challenge. While antipsychotic medications have proven efficacy in this disease, there remains an opportunity to further improve symptom control and long-term relapse prevention.
Dimmer Switch For New Class Of Schizophrenia...
Schizophrenia affects about one percent of the world's population and, if untreated, leaves sufferers struggling with their relationships, jobs, and lives as a whole.
Thu Aug 14, 2014
The patient complained of insects crawling on her skin. Then she handed me a glass jar
Erica was hugely frustrated. "I've had the council round several times, they've fumigated the whole place twice, and still I'm getting bitten."
a systemically-available kynurenine aminotransferase II (Kat II)...
Kynurenic acid is a tryptophan metabolite that acts in the brain as an endogenous antagonist at multiple receptors, including glutamate and I 7 nicotinic acetylcholine receptors.
Wed Aug 13, 2014
Use of quetiapine XR and quetiapine IR in clinical practice for...
Quetiapine fumarate, a first-line treatment for schizophrenia, exists in two formulations: extended release and immediate release .
Tue Aug 12, 2014
Intra-Cellular Therapies, Inc. - 10-Q - Management's Discussion and...
You should read the following in conjunction with our unaudited condensed consolidated financial statements and the related notes thereto that appear elsewhere in this Quarterly Report on Form 10-Q and the audited consolidated financial statements and notes thereto and under the heading "Management's Discussion and Analysis of Financial Condition ... (more)
Aim for Next-Gen Schizophrenia Drugs Is Dimming Symptoms Without Side Effects
The approach is heralded as a method to manage the symptoms of schizophrenia without some of the side effects associated with current anti-psychotic medicines.
Mon Aug 11, 2014
Review: Fringe theatre
At least. The space itself is divided in two, with a separate drama running simultaneously on either side.
The Diagnosis of Schizophrenia in One's Child or Adolescent
Prior to the assessment of schizophrenia in children and adolescents, there are important considerations to be addressed by the parents of youths exhibiting behavior problems .
'Dimmer switch' drug idea could tackle schizophrenia
Affecting one per cent of the world's population, schizophrenia is a major health condition.